TY - JOUR
T1 - Stereotactic ablative radiation therapy for primary lung tumors
AU - Heinzerling, John H.
AU - Kavanagh, Brian
AU - Timmerman, Robert D.
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2011/1
Y1 - 2011/1
N2 - Stereotactic ablative radiotherapy, also known as stereotactic body radiation therapy, has been developed as an innovative therapy for stage I non-small cell lung cancer and has now emerged as a standard treatment option for medically inoperable patients through careful analysis utilizing prospective, multi-institutional trials. This article reviews and updates the evidence for use of stereotactic ablative radiotherapy in medically inoperable patients with stage I lung cancer, its extension of use to medically operable patients, and the toxicities associated with this emerging technique.
AB - Stereotactic ablative radiotherapy, also known as stereotactic body radiation therapy, has been developed as an innovative therapy for stage I non-small cell lung cancer and has now emerged as a standard treatment option for medically inoperable patients through careful analysis utilizing prospective, multi-institutional trials. This article reviews and updates the evidence for use of stereotactic ablative radiotherapy in medically inoperable patients with stage I lung cancer, its extension of use to medically operable patients, and the toxicities associated with this emerging technique.
KW - Stereotactic ablative radiotherapy (SABR)
KW - innovative therapy
KW - non-small cell lung cancer (NSCLC)
KW - stage I lung cancer
KW - stereotactic body radiation therapy
UR - http://www.scopus.com/inward/record.url?scp=79551573509&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79551573509&partnerID=8YFLogxK
U2 - 10.1097/PPO.0b013e31820a7f80
DO - 10.1097/PPO.0b013e31820a7f80
M3 - Review article
C2 - 21263264
AN - SCOPUS:79551573509
SN - 1528-9117
VL - 17
SP - 28
EP - 32
JO - Cancer Journal
JF - Cancer Journal
IS - 1
ER -